The deal stands to drive hundreds of millions more to the local company over time.
Image: Scott Koenig is president and CEO of Rockville’s MacroGenics. JOANNE S. LAWTON
{iframe}https://www.bizjournals.com/washington/news/2023/03/10/diabetes-drug-tzield-rockville-biotech-sells.html{/iframe}